Table 6 Top 20 novel genes exhibiting genome-wide significance for the TyG index, a marker of insulin resistance, identified within the Taiwan Biobank cohort

From: Gene clusters linked to insulin resistance identified in a genome-wide study of the Taiwan Biobank population

CHR

Rank

Gene

Top SNP

Top P

Interval (b38)

GWAS catalog

2

4

SPATA31H1

rs1919127

6.90E-114

27,576,521

27,582,722

NA

2

3

ZNF512

rs12989678

1.30E-115

27,582,968

27,623,215

T2D, TG

2

13

GPN1

rs34502053

7.90E-68

27,628,647

27,650,846

TG, FG, BMI

2

17

SUPT7L

rs4666010

9.90E-45

27,650,809

27,663,840

NA

2

15

SLC4A1AP

rs13021208

1.60E−57

27,663,470

27,694,980

AD, TG

2

19

RBKS

rs898034

1.50E-38

27,781,379

27,890,387

TG

2

20

MRPL33

rs3792252

2.20E-37

27,771,719

27,779,733

TG, FG

7

12

FZD9

rs1178947

5.80E-69

73,433,778

73,436,120

TG, HDL-C

7

11

BAZ1B

rs111837003

1.20E-71

73,440,406

73,522,293

TG, HDL-C

7

9

BCL7B

rs7793710

1.10E-83

73,536,352

73,557,735

HDL-C

7

8

TBL2

rs13246490

2.60E-84

73,568,945

73,578,683

TG, HDL-C, BMI

11

1

BUD13

rs6589565

7.3E-445

116,748,173

116,772,987

TG, HDL-C

11

2

APOC3

rs5128

2.80E-152

116,829,907

116,833,071

TG, HDL-C

11

18

APOA1

rs12718464

3.10E-39

116,835,752

116,837,622

TG, HDL-C, BMI

11

10

PAFAH1B2

rs7925256

8.00E-75

117,144,283

117,178,173

TG, HDL-C, BMI

11

14

SIDT2

rs6589603

1.10E−59

117,178,743

117,197,442

TG, HDL-C

11

16

TAGLN

rs588534

3.40E−51

117,199,294

117,207,465

TG, HDL-C

19

6

NECTIN2

rs283811

1.60E-94

44,846,135

44,889,228

AD, T2D, TG, HDL-C, BMI

19

7

TOMM40

rs157582

7.50E-94

44,891,219

44,903,689

AD, TG, HDL-C, BMI

19

5

APOE

rs440446

1.70E-106

44,905,796

44,909,393

AD, T2D, TG, HDL-C, BMI

  1. AD Alzheimer’s disease, b38 Genome Research Consortium human build 38, BMI body mass index, CHR chromosome, FG fasting glucose, HDL-C high-density lipoprotein cholesterol, IR insulin resistance, NA not available, Pos position, T2D type 2 diabetes, TAD topologically associating domains, TG triglycerides.
  2. Previous GWASs reported in the NHGRI-EBI GWAS Catalog have identified various phenotypes that reach genome-wide significance (P < 5 × 10−8). This GWAS analysis utilized BOLT-LMM’s mixed linear models with a two-sided chi-square test. The conventional genome-wide significance threshold of P < 5 × 10−8 was applied.